Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

The Lyme disease spirochete's BpuR DNA/RNA-binding protein is differentially expressed during the mammal-tick infectious cycle, which affects translation of the SodA superoxide dismutase.

Jutras BL, Savage CR, Arnold WK, Lethbridge KG, Carroll DW, Tilly K, Bestor A, Zhu H, Seshu J, Zückert WR, Stewart PE, Rosa PA, Brissette CA, Stevenson B.

Mol Microbiol. 2019 Sep;112(3):973-991. doi: 10.1111/mmi.14336. Epub 2019 Jul 7.

2.

TICK TOCK-Time Is Running Out, as the United States Is Being Invaded by the Longhorned Tick!

Brissette CA.

Vector Borne Zoonotic Dis. 2019 May;19(5):307-308. doi: 10.1089/vbz.2019.2473. Epub 2019 Apr 9. No abstract available.

PMID:
30964394
3.

DNA Methylation by Restriction Modification Systems Affects the Global Transcriptome Profile in Borrelia burgdorferi.

Casselli T, Tourand Y, Scheidegger A, Arnold WK, Proulx A, Stevenson B, Brissette CA.

J Bacteriol. 2018 Nov 26;200(24). pii: e00395-18. doi: 10.1128/JB.00395-18. Print 2018 Dec 15.

4.

Transcriptomic insights on the virulence-controlling CsrA, BadR, RpoN, and RpoS regulatory networks in the Lyme disease spirochete.

Arnold WK, Savage CR, Lethbridge KG, Smith TC 2nd, Brissette CA, Seshu J, Stevenson B.

PLoS One. 2018 Aug 30;13(8):e0203286. doi: 10.1371/journal.pone.0203286. eCollection 2018.

5.

Primary Human Microglia Are Phagocytically Active and Respond to Borrelia burgdorferi With Upregulation of Chemokines and Cytokines.

Greenmyer JR, Gaultney RA, Brissette CA, Watt JA.

Front Microbiol. 2018 Apr 25;9:811. doi: 10.3389/fmicb.2018.00811. eCollection 2018.

6.

Design of a Lyme Disease Vaccine as an Active Learning Approach in a Novel Interdisciplinary Graduate-Level Course.

Jessen Condry DL, Bradley DS, Brissette CA.

J Microbiol Biol Educ. 2017 Oct 4;18(3). pii: 18.3.52. doi: 10.1128/jmbe.v18i3.1304. eCollection 2017.

7.

Borrelia burgdorferi adhere to blood vessels in the dura mater and are associated with increased meningeal T cells during murine disseminated borreliosis.

Divan A, Casselli T, Narayanan SA, Mukherjee S, Zawieja DC, Watt JA, Brissette CA, Newell-Rogers MK.

PLoS One. 2018 May 3;13(5):e0196893. doi: 10.1371/journal.pone.0196893. eCollection 2018.

8.

Borrelia burgdorferi SpoVG DNA- and RNA-Binding Protein Modulates the Physiology of the Lyme Disease Spirochete.

Savage CR, Jutras BL, Bestor A, Tilly K, Rosa PA, Tourand Y, Stewart PE, Brissette CA, Stevenson B.

J Bacteriol. 2018 May 24;200(12). pii: e00033-18. doi: 10.1128/JB.00033-18. Print 2018 Jun 15.

9.

Brave New Worlds: The Expanding Universe of Lyme Disease.

Stone BL, Tourand Y, Brissette CA.

Vector Borne Zoonotic Dis. 2017 Sep;17(9):619-629. doi: 10.1089/vbz.2017.2127. Epub 2017 Jul 20. Review.

10.

Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Borrelia miyamotoi.

Stone BL, Brissette CA.

Front Immunol. 2017 Jan 19;8:12. doi: 10.3389/fimmu.2017.00012. eCollection 2017. Review.

11.

MicroRNA and mRNA Transcriptome Profiling in Primary Human Astrocytes Infected with Borrelia burgdorferi.

Casselli T, Qureshi H, Peterson E, Perley D, Blake E, Jokinen B, Abbas A, Nechaev S, Watt JA, Dhasarathy A, Brissette CA.

PLoS One. 2017 Jan 30;12(1):e0170961. doi: 10.1371/journal.pone.0170961. eCollection 2017.

12.

RNA-Seq of Borrelia burgdorferi in Multiple Phases of Growth Reveals Insights into the Dynamics of Gene Expression, Transcriptome Architecture, and Noncoding RNAs.

Arnold WK, Savage CR, Brissette CA, Seshu J, Livny J, Stevenson B.

PLoS One. 2016 Oct 5;11(10):e0164165. doi: 10.1371/journal.pone.0164165. eCollection 2016.

13.

Laboratory Cultivation and Maintenance of Borrelia miyamotoi.

Stone BL, Brissette CA.

Curr Protoc Microbiol. 2016 Aug 12;42:12F.1.1-6. doi: 10.1002/cpmc.12.

PMID:
27517334
14.

Escherichia coli lipoprotein binds human plasminogen via an intramolecular domain.

Gonzalez T, Gaultney RA, Floden AM, Brissette CA.

Front Microbiol. 2015 Oct 7;6:1095. doi: 10.3389/fmicb.2015.01095. eCollection 2015.

15.

Borrelia burgdorferi RevA Significantly Affects Pathogenicity and Host Response in the Mouse Model of Lyme Disease.

Byram R, Gaultney RA, Floden AM, Hellekson C, Stone BL, Bowman A, Stevenson B, Johnson BJ, Brissette CA.

Infect Immun. 2015 Sep;83(9):3675-83. doi: 10.1128/IAI.00530-15. Epub 2015 Jul 6.

16.

Lyme disease: recent advances and perspectives.

Petnicki-Ocwieja T, Brissette CA.

Front Cell Infect Microbiol. 2015 Apr 1;5:27. doi: 10.3389/fcimb.2015.00027. eCollection 2015. No abstract available.

17.

Epigenetics of inflammation, maternal infection, and nutrition.

Claycombe KJ, Brissette CA, Ghribi O.

J Nutr. 2015 May;145(5):1109S-1115S. doi: 10.3945/jn.114.194639. Epub 2015 Apr 1. Review.

18.

The Western progression of lyme disease: infectious and Nonclonal Borrelia burgdorferi Sensu Lato populations in Grand Forks County, North Dakota.

Stone BL, Russart NM, Gaultney RA, Floden AM, Vaughan JA, Brissette CA.

Appl Environ Microbiol. 2015 Jan;81(1):48-58. doi: 10.1128/AEM.02422-14. Epub 2014 Oct 10.

19.

That's my story, and I'm sticking to it--an update on B. burgdorferi adhesins.

Brissette CA, Gaultney RA.

Front Cell Infect Microbiol. 2014 Apr 3;4:41. doi: 10.3389/fcimb.2014.00041. eCollection 2014. Review.

20.

BB0347, from the lyme disease spirochete Borrelia burgdorferi, is surface exposed and interacts with the CS1 heparin-binding domain of human fibronectin.

Gaultney RA, Gonzalez T, Floden AM, Brissette CA.

PLoS One. 2013 Sep 27;8(9):e75643. doi: 10.1371/journal.pone.0075643. eCollection 2013.

21.

The multifaceted responses of primary human astrocytes and brain microvascular endothelial cells to the Lyme disease spirochete, Borrelia burgdorferi.

Brissette CA, Kees ED, Burke MM, Gaultney RA, Floden AM, Watt JA.

ASN Neuro. 2013 Aug 16;5(3):221-9. doi: 10.1042/AN20130010.

22.

Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease.

Floden AM, Gonzalez T, Gaultney RA, Brissette CA.

Clin Vaccine Immunol. 2013 Jun;20(6):892-9. doi: 10.1128/CVI.00758-12. Epub 2013 Apr 17.

23.

Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis.

Brissette CA, Houdek HM, Floden AM, Rosenberger TA.

J Neuroinflammation. 2012 Nov 7;9:249. doi: 10.1186/1742-2094-9-249.

24.

EbfC (YbaB) is a new type of bacterial nucleoid-associated protein and a global regulator of gene expression in the Lyme disease spirochete.

Jutras BL, Bowman A, Brissette CA, Adams CA, Verma A, Chenail AM, Stevenson B.

J Bacteriol. 2012 Jul;194(13):3395-406. doi: 10.1128/JB.00252-12. Epub 2012 Apr 27.

25.

BpaB and EbfC DNA-binding proteins regulate production of the Lyme disease spirochete's infection-associated Erp surface proteins.

Jutras BL, Verma A, Adams CA, Brissette CA, Burns LH, Whetstine CR, Bowman A, Chenail AM, Zückert WR, Stevenson B.

J Bacteriol. 2012 Feb;194(4):778-86. doi: 10.1128/JB.06394-11. Epub 2011 Dec 9.

26.

Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein.

Floden AM, Watt JA, Brissette CA.

PLoS One. 2011;6(11):e27502. doi: 10.1371/journal.pone.0027502. Epub 2011 Nov 8.

27.

Simultaneous isolation of Ixodidae and bacterial (Borrelia spp.) genomic DNA.

Jutras BL, Liu Z, Brissette CA.

Curr Protoc Microbiol. 2010 Nov;Chapter 1:Unit1E.2. doi: 10.1002/9780471729259.mc01e02s19.

PMID:
21053250
28.

Leptospiral endostatin-like protein A is a bacterial cell surface receptor for human plasminogen.

Verma A, Brissette CA, Bowman AA, Shah ST, Zipfel PF, Stevenson B.

Infect Immun. 2010 May;78(5):2053-9. doi: 10.1128/IAI.01282-09. Epub 2010 Feb 16.

29.

The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease.

Brissette CA, Rossmann E, Bowman A, Cooley AE, Riley SP, Hunfeld KP, Bechtel M, Kraiczy P, Stevenson B.

Clin Vaccine Immunol. 2010 Feb;17(2):274-80. doi: 10.1128/CVI.00437-09. Epub 2009 Dec 23.

30.

Functional characterization of Borrelia spielmanii outer surface proteins that interact with distinct members of the human factor H protein family and with plasminogen.

Seling A, Siegel C, Fingerle V, Jutras BL, Brissette CA, Skerka C, Wallich R, Zipfel PF, Stevenson B, Kraiczy P.

Infect Immun. 2010 Jan;78(1):39-48. doi: 10.1128/IAI.00691-09. Epub 2009 Oct 26.

31.

Borrelia burgdorferi BmpA is a laminin-binding protein.

Verma A, Brissette CA, Bowman A, Stevenson B.

Infect Immun. 2009 Nov;77(11):4940-6. doi: 10.1128/IAI.01420-08. Epub 2009 Aug 24.

32.

Borrelia burgdorferi RevA antigen binds host fibronectin.

Brissette CA, Bykowski T, Cooley AE, Bowman A, Stevenson B.

Infect Immun. 2009 Jul;77(7):2802-12. doi: 10.1128/IAI.00227-09. Epub 2009 Apr 27.

33.

The Borrelia burgdorferi outer-surface protein ErpX binds mammalian laminin.

Brissette CA, Verma A, Bowman A, Cooley AE, Stevenson B.

Microbiology. 2009 Mar;155(Pt 3):863-72. doi: 10.1099/mic.0.024604-0.

PMID:
19246757
34.

Borrelia burgdorferi EbfC defines a newly-identified, widespread family of bacterial DNA-binding proteins.

Riley SP, Bykowski T, Cooley AE, Burns LH, Babb K, Brissette CA, Bowman A, Rotondi M, Miller MC, DeMoll E, Lim K, Fried MG, Stevenson B.

Nucleic Acids Res. 2009 Apr;37(6):1973-83. doi: 10.1093/nar/gkp027. Epub 2009 Feb 10.

35.

Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen.

Brissette CA, Haupt K, Barthel D, Cooley AE, Bowman A, Skerka C, Wallich R, Zipfel PF, Kraiczy P, Stevenson B.

Infect Immun. 2009 Jan;77(1):300-6. doi: 10.1128/IAI.01133-08. Epub 2008 Nov 10.

36.

Treponema denticola does not induce production of common innate immune mediators from primary gingival epithelial cells.

Brissette CA, Pham TT, Coats SR, Darveau RP, Lukehart SA.

Oral Microbiol Immunol. 2008 Dec;23(6):474-81. doi: 10.1111/j.1399-302X.2008.00452.x.

37.

Lyme borreliosis spirochete Erp proteins, their known host ligands, and potential roles in mammalian infection.

Brissette CA, Cooley AE, Burns LH, Riley SP, Verma A, Woodman ME, Bykowski T, Stevenson B.

Int J Med Microbiol. 2008 Sep 1;298 Suppl 1:257-67. doi: 10.1016/j.ijmm.2007.09.004. Epub 2008 Jan 11. Review.

38.

Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle.

Bykowski T, Woodman ME, Cooley AE, Brissette CA, Wallich R, Brade V, Kraiczy P, Stevenson B.

Int J Med Microbiol. 2008 Sep 1;298 Suppl 1:249-56. doi: 10.1016/j.ijmm.2007.10.002. Epub 2007 Dec 31. Review.

39.

Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Kraiczy P, Seling A, Brissette CA, Rossmann E, Hunfeld KP, Bykowski T, Burns LH, Troese MJ, Cooley AE, Miller JC, Brade V, Wallich R, Casjens S, Stevenson B.

Clin Vaccine Immunol. 2008 Mar;15(3):484-91. Epub 2007 Dec 26.

40.

Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement.

Stevenson B, Choy HA, Pinne M, Rotondi ML, Miller MC, Demoll E, Kraiczy P, Cooley AE, Creamer TP, Suchard MA, Brissette CA, Verma A, Haake DA.

PLoS One. 2007 Nov 14;2(11):e1188.

41.

Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete's mammal-tick infection cycle.

Bykowski T, Woodman ME, Cooley AE, Brissette CA, Brade V, Wallich R, Kraiczy P, Stevenson B.

Infect Immun. 2007 Sep;75(9):4227-36. Epub 2007 Jun 11.

42.

Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola.

Brissette CA, Lukehart SA.

Infect Immun. 2007 May;75(5):2307-15. Epub 2007 Feb 26.

43.

Resistance to human beta-defensins is common among oral treponemes.

Brissette CA, Simonson LG, Lukehart SA.

Oral Microbiol Immunol. 2004 Dec;19(6):403-7.

PMID:
15491467
44.

Treponema denticola is resistant to human beta-defensins.

Brissette CA, Lukehart SA.

Infect Immun. 2002 Jul;70(7):3982-4.

45.

Actinobacillus actinomycetemcomitans may utilize either actin-dependent or actin-independent mechanisms of invasion.

Brissette CA, Fives-Taylor PM.

Oral Microbiol Immunol. 1999 Jun;14(3):137-42.

PMID:
10495707

Supplemental Content

Loading ...
Support Center